经皮耳神经刺激(神经调控)治疗疼痛:以全关节置换术模拟战创伤的概念验证病例报告
本文为概念验证病例报告,以全关节置换术模拟战创伤,评估經皮耳神经调控的镇痛可行性。2例患者在脊髓麻醉下接受开放全膝或全髋关节置换术后,于恢复室佩戴耳神经调控装置,带装置出院并每日随访7天。装置均在3分钟内贴好、耐受良好、第5天在家无并发症移除;使用期间两例患者躺、坐、行走时均无疼痛,除计划性塞来昔布外,仅1例因坐下时疼痛于术后第3、4天各用1片曲马多50mg。第6、7天两例疼痛加重,其中1例需按时给予曲马多。作者认为该技术可行,似乎明显减轻疼痛和阿片需求且无全身副作用,值得进一步研究。
要点
- 2例脊髓麻醉下开放全膝或全髋置换术后患者在恢复室佩戴经皮耳神经调控装置,均在3分钟内完成贴附且无困难。
- 装置使用期间两例患者躺、坐、行走时均无疼痛,除计划性塞来昔布外仅1例于术后第3、4天各用1片曲马多50mg(坐下时疼痛)。
- 装置耐受良好,第5天在家无并发症移除;第6、7天两例疼痛加重,其中1例需按时给予曲马多。
- 作者认为,在此2例中该技术似乎明显减轻了疼痛评分和阿片需求,且无全身副作用。
- 证据等级为治疗/护理管理Level V,作者认为需进一步研究。
适用人群与场景
- 在脊髓麻醉下接受开放全膝关节或全髋关节置换术的2例患者,作为战创伤的模拟模型。
处置流程与药物剂量
- 术后在恢复室由医务人员贴附经皮耳神经调控装置,均在3分钟内完成。
- 患者带装置出院,每日电话随访7天,第5天在家移除装置。
- 使用期间除计划性塞来昔布外,1例因坐下时疼痛于术后第3、4天各用1片曲马多50mg;第6、7天两例疼痛加重,其中1例需按时给予曲马多。
研究设计与关键结果
- 研究类型:概念验证病例报告,样本量2例,以全关节置换术模拟战创伤,评估经皮耳神经调控的镇痛可行性。
- 装置贴附均在3分钟内完成且无困难,使用期间耐受良好,第5天在家移除无并发症。
- 使用期间两例患者躺、坐、行走时均无疼痛;除计划性塞来昔布外,仅1例于术后第3、4天各用1片曲马多50mg(坐下时疼痛)。
- 第6、7天两例疼痛加重,其中1例需按时给予曲马多。
证据类型、等级与局限
- 证据类型:病例报告(概念验证),证据等级:治疗/护理管理Level V。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在此2例中经皮耳神经调控似乎明显减轻了术后一周内的疼痛评分和阿片需求,且无全身副作用。
- 作者认为,考虑到该 modality 无需全身副作用即可治疗战创伤的潜力,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There are few effective pain treatments following trauma on the battlefield other than opioids, which are limited by respiratory depression. Ultrasound-guided percutaneous peripheral nerve stimulation ("neuromodulation") has been proposed as an analgesic, but requires physician-level skills, advanced equipment, and an hour to administer. In contrast, percutaneous auricular neuromodulation may be placed by a medic in the field under nonsterile conditions in a few minutes, theoretically provides analgesia for any anatomic location, has no side effects, and no significant risks. It therefore offers the potential to be applied quickly on the battlefield without any of the limitations of opioids. We propose total joint replacement as a surrogate for battlefield trauma and here present a case report to demonstrate proof of concept.
METHODS: Following open total knee or hip arthroplasty under spinal anesthesia, two patients had an auricular neuromodulation device applied within the recovery room. Patients were discharged with the unit and contacted daily for 7 days.
RESULTS: The devices were each applied in under 3 minutes without difficulty, were well tolerated during use, and removed without complication at home on Day 5. During use, neither patient experienced pain while lying, sitting, or ambulating. Neither required analgesics other than scheduled celecoxib; and a single tablet (50 mg) of tramadol for one patient on postoperative Days 3 and 4 for pain while lowering herself to a seated position. On Days 6 and 7, both patients experienced an increase in pain, one of whom required around-the-clock tramadol.
CONCLUSION: Ambulatory postoperative percutaneous auricular neuromodulation is feasible. In these two cases, it appears to have markedly reduced pain scores and opioid requirements free of systemic side effects during the week following major orthopedic surgery. Considering the potential of this modality to treat trauma on the battlefield without systemic side effects, additional investigation appears warranted.
LEVEL OF EVIDENCE: Therapeutic/care management; Level V.
参考来源
- Ilfeld BM, Finneran JJ, Said ET, et al. Percutaneous auricular nerve stimulation (neuromodulation) for the treatment of pain: A proof-of-concept case report using total joint arthroplasty as a surrogate for battlefield trauma. J Trauma Acute Care Surg. 2022. PMID: 35594419. doi:10.1097/TA.0000000000003706
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。